Home / Inspections / 1113084

FDA Inspection 1113084 — Sanofi Aventis Singapore Pte. Ltd.

Sanofi Aventis Singapore Pte. Ltd. — FEI 3003091951

The FDA completed an inspection of Sanofi Aventis Singapore Pte. Ltd. on November 1, 2019 in Singapore. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
November 1, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Singapore (Singapore)

Facility

Other inspections at this facility

  • 1274305 (VAI Fri Jun 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1032305 (VAI Fri Oct 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 933845 (VAI Fri May 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 773423 (NAI Fri Mar 09 2012 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 677605 (VAI Thu Jul 15 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources